Lung Cancer Clinical Trials

Showing 1621-1640 of 3,692 trials

High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer

NCT03870529

This trial studies how well high dose vitamin A compound works in treating participants with non-small cell lung cancer that can be removed by surgery. Vitamin A compound may increase the number of germinal centers (immune centers that make antibodies mature) in tumor and lymph tissues which may be beneficial to patients with cancer.

Non Small Cell Lung CancerStage I Lung CancerStage Ib Lung Carcinoma+3 more

Wake Forest University Health Sciences20 participantsStarted Aug 2019

Winston-Salem, North Carolina, United States

RECRUITINGNA

Non-risk Based Lang Cancer Screening With a One-off LDCT

NCT04938804

Guangzhou Lung-Care Project is a single-arm, prospective cohort study using one-time low-dose computed tomography for the early detection of LC, recruiting residents aged 40-74 years from four communities in Guangzhou between 2015 and 2021.The primary outcome was LC detection rate in eligible participants without restrictions based on high-risk factors and the proportion of stage I LC cases, and to investigate the various factors associated with the development of LC.

Lung Cancer

The First Affiliated Hospital of Guangzhou Medical University11,000 participantsStarted Dec 2015

Guangzhou, Guangdong, China

UNKNOWNPhase 1

Thoracic Consolidation Radiotherapy for ES-SCLC Treated With Chemo-immunotherapy

NCT06187740

This study intends to recruit ES-SCLC patients with response to standard first-line chemo-immunotherapy to assess the safety of receiving different doses of consolidative thoracic radiotherapy.

Small Cell Lung Cancer Extensive Stage

Fudan University28 participantsStarted Dec 2023

Shanghai, Shanghai Municipality, China

High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer

Non-risk Based Lang Cancer Screening With a One-off LDCT

Thoracic Consolidation Radiotherapy for ES-SCLC Treated With Chemo-immunotherapy

Related Searches

A Prehabilitation Program to Boost Postoperative Functional Capacity in Surgical Lung Cancer Patients

Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium

A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer Patients

To Assess the Efficacy and Safety of Furmonertinib in Patients With Epidermal Growth Factor Receptor 20ins Mutation Positive Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy

The Efficacy and Safety of Drug Loaded Microsphere Bronchial Artery Chemoembolization (DEB-BACE) Combined With Anlotinib and Adebelimumab in the Third Line Treatment of Advanced NSCLC: a Prospective, Single Arm, Single Center, Exploratory Clinical Study

Olaparib and Bevacizumab in Relapsed Small Cell Lung Cancer Subjects

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

I-125 Seeds Implantation in the Treatment of Recurrent Lung Cancer After Radiotherapy

LITT and Pembrolizumab in Recurrent Brain Metastasis

Real-World Study on the Efficacy of IBI-322 in Combination With Lenvatinib for the Treatment of Extensive Stage Small Cell Lung Cancer

Study of Anlotinib Combined With Docetaxel in Non-Driver Mutation Non-squamous NSCLC: the Save Study

A Study of Sunvozertinib Combined With Anlotinib in Local Advanced or Metastatic Non-small Cell Lung Cancer

Real World Study on First Line Crizotinib in ROS1 Rearranged Advanced Non-squamous Non-small Cell Lung Cancer

Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer

Chemotherapy or Chemotherapy Plus PD-1 Antibody in RET Fusion Positive Advanced NSCLC Patitnts: the POSEIDON Trial

Stereotactic Body Radiotherapy for the Treatment of OPD

CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab